Yahoo Web Search

Search results

1. • Weaker demand for its Covid-19 vaccines

     • Moderna shares tumbled after the pharmaceutical company lowered its sales guidance due to weaker demand for its Covid-19 vaccines.
     www.wsj.com/livecoverage/stock-market-today-earnings-dow-sp500-nasdaq-live-08-01-2024/card/moderna-stock-slides-after-vaccine-maker-cuts-guidance-YbmmjlTQiN5GW3hnnAE7

     Moderna Stock Plunges After Vaccine Maker Cuts Guidance

2. People also ask

   Why did Moderna stock fall 14%?

   • S&P 500 falls 1.4%, while Meta stock remains a bright spot after earnings. Moderna shares tumbled after the pharmaceutical company lowered its sales guidance due to weaker demand for its Covid-19 vaccines.

   Moderna Stock Plunges After Vaccine Maker Cuts Guidance

   www.wsj.com/livecoverage/stock-market-today-earnings-dow-sp500-nasdaq-live-08-01-2024/card/moderna-stock-slides-after-vaccine-maker-cuts-guidance-YbmmjlTQiN5GW3hnnAE7

   See all results for this question

   Why did Moderna stock drop 2024?

   • Moderna ( MRNA) shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the European Union. The company said it now expects total sales between $3 billion and $3.5 billion for the year. That's down from the $4 billion forecast in the first quarter.

   Who's to blame as Moderna's stock falls amid slashed guidance?

   finance.yahoo.com/news/whos-to-blame-as-modernas-stock-falls-amid-slashed-guidance-183107018.html

   See all results for this question

   Will Moderna stock gain in value over the long term?

   • There is still reason to hope that its shares will gain in value over the long term. There's no hope of it recovering to its prior heights anytime soon. Moderna 's (MRNA -2.63%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a handful of its pipeline programs and terminate a few others.

   Down 13% in 1 Day, Is Moderna Stock in Trouble?

   www.fool.com/investing/2024/09/20/down-13-in-1-day-is-moderna-stock-in-trouble/

   See all results for this question

   Is Moderna a good stock to buy?

   • From a valuation standpoint, Moderna appears attractive compared to the industry. Going by the price/sales (P/S) ratio, the company’s shares currently trade at 4.36, trailing 12-month sales value, lower than 8.21 for the industry. Estimates for Moderna’s 2024 loss per share have increased from $9.37 to $9.85 in the past 60 days.

   Moderna Stock Falls 20% in a Month: Time to Sell or Hold?

   finance.yahoo.com/news/moderna-stock-falls-20-month-134800976.html

   See all results for this question

   Why did Moderna shares tumble?

   • Moderna shares tumbled after the pharmaceutical company lowered its sales guidance due to weaker demand for its Covid-19 vaccines. Moderna now projects 2024 net sales of between $3 billion and $3.5 billion, versus previous guidance of about $4 billion, citing an increasingly competitive environment

   Moderna Stock Plunges After Vaccine Maker Cuts Guidance

   www.wsj.com/livecoverage/stock-market-today-earnings-dow-sp500-nasdaq-live-08-01-2024/card/moderna-stock-slides-after-vaccine-maker-cuts-guidance-YbmmjlTQiN5GW3hnnAE7

   See all results for this question

   How much will Moderna stock lose in the third quarter?

   • For the third quarter, Moderna stock analysts project adjusted losses of $2.69 per share and $1.23 billion in sales. Sales are expected to accelerate again in the fourth quarter with projections for $1.59 billion. But analysts still project steep losses this year and a nearly 52% drop in sales.

   Is Moderna Stock A Sell After The Company Slashed Its R&D Budget?

   www.investors.com/news/technology/mrna-stock-buy-now/

   See all results for this question

3. finance.yahoo.com › news › whos-to-blame-as-modernasWho's to blame as Moderna's stock falls amid slashed guidance?

   finance.yahoo.com › news › whos-to-blame-as-modernas

   • Cached

   Aug 1, 2024 · Moderna shares slid more than 20% Thursday after the company slashed its sales guidance for 2024, largely because of a lack of new COVID-19 vaccine orders from the European Union.

   • Moderna Stock Falls 20% in a Month: Time to Sell or Hold?

     Despite giving the world one of the first and most widely...

4. finance.yahoo.com › news › moderna-mrna-stock-sinksModerna (MRNA) Stock Sinks As Market Gains: Here's Why

   finance.yahoo.com › news › moderna-mrna-stock-sinks

   • Cached

   Oct 14, 2024 · Heading into today, shares of the biotechnology company had lost 14.63% over the past month, lagging the Medical sector's loss of 3% and the S&P 500's gain of 4.87% in that time.

5. Videos

   • 

     4:06

     youtube.com

     Why Moderna's stock is falling after Merck's Covid pill announcement

     1 Oct 2021

     28.6K views

   • 

     3:33

     youtube.com

     Moderna stock hits all time high

     9 Aug 2021

     9.3K views

   • 

     2:21

     finance.yahoo.com

     Moderna stock decline: What it will take to get it moving higher again

     27 Oct 2023

   View all

6. www.investors.com › news › technologyIs Moderna Stock A Sell After The Company Slashed Its R&D ...

   www.investors.com › news › technology

   3 days ago · The RS Rating is a 1-99 measure of a stock's 12-month performance. This means Moderna stock outranks just 4% of all stocks on that metric. But MRNA stock has a poor EPS Rating of 15,...

7. www.morningstar.com › news › marketwatchModerna's stock falls after data shows biotech's RSV vaccine ...

   www.morningstar.com › news › marketwatch

   • Cached

   Jun 26, 2024 · Moderna Inc.'s stock fell 9% Wednesday, after the company said that its respiratory syncytial virus, or RSV, shot showed 50% efficacy in preventing the illness after 18 months. The...

8. finance.yahoo.com › news › moderna-stock-falls-20Moderna Stock Falls 20% in a Month: Time to Sell or Hold?

   finance.yahoo.com › news › moderna-stock-falls-20

   • Cached

   Despite giving the world one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have lost significantly in the past couple of years due to declining sales amid low demand...

9. www.fool.com › investing › 2024/09/20Down 13% in 1 Day, Is Moderna Stock in Trouble ... - The ...

   www.fool.com › investing › 2024/09/20

   • Cached

   Sep 20, 2024 · Moderna 's (MRNA 3.22%) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a handful of its pipeline programs and terminate a few others. Now,...

10. www.wsj.com › livecoverage › stock-market-todayModerna Stock Plunges After Vaccine Maker Cuts Guidance

    www.wsj.com › livecoverage › stock-market-today

    • Cached

    Aug 1, 2024 · Moderna shares tumbled after the pharmaceutical company lowered its sales guidance due to weaker demand for its Covid-19 vaccines. Moderna now projects 2024 net sales of between $3 billion and...